{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T04:00:25Z","timestamp":1773288025699,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2003,10,1]],"date-time":"2003-10-01T00:00:00Z","timestamp":1064966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2003,10,1]],"date-time":"2003-10-01T00:00:00Z","timestamp":1064966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2003,10]]},"DOI":"10.1124\/dmd.31.10.1203","type":"journal-article","created":{"date-parts":[[2003,9,15]],"date-time":"2003-09-15T17:58:12Z","timestamp":1063648692000},"page":"1203-1207","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["PLASMA BINDING OF TRICHLOROACETIC ACID IN MICE, RATS, AND HUMANS UNDER CANCER BIOASSAY AND ENVIRONMENTAL EXPOSURE CONDITIONS"],"prefix":"10.1016","volume":"31","author":[{"given":"Michael H.","family":"Lumpkin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James V.","family":"Bruckner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerry L.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cham E.","family":"Dallas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine A.","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey W.","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.31.10.1203_bib1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1006\/taap.1997.8190","article-title":"A physiologically based pharmacokinetic model for trichloroethylene and its metabolites, chloral hydrate, trichloroacetate, dichloroacetate, trichloroethanol and trichloroethanol glucuronide in B6C3F1 mice.","volume":"127","author":"Abbas","year":"1997","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1124\/dmd.31.10.1203_bib2","series-title":"Toxicological Profile for Trichloroethylene (Update).","year":"1997"},{"key":"10.1124\/dmd.31.10.1203_bib3","series-title":"Toxicological Profile for Tetrachloroethylene (Update).","year":"1997"},{"issue":"Suppl 2","key":"10.1124\/dmd.31.10.1203_bib4","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1289\/ehp.00108s2241","article-title":"Mode of action of liver tumor induction by trichloroethylene and its metabolites, trichloroacetate and dichloroacetate.","volume":"108","author":"Bull","year":"2000","journal-title":"Environ Health Perspect"},{"key":"10.1124\/dmd.31.10.1203_bib5","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/BF00435845","article-title":"Could interspecies differences in the protein binding of flavone acetic acid contribute to the failure to predict lack of efficacy in patients?","volume":"23","author":"Cassidy","year":"1989","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1124\/dmd.31.10.1203_bib6","doi-asserted-by":"crossref","first-page":"435","DOI":"10.2165\/00003088-199324060-00001","article-title":"Plasma protein binding and pharmacological response.","volume":"24","author":"du Souich","year":"1993","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/dmd.31.10.1203_bib7","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0278-6915(97)00090-2","article-title":"Development of a priority list of chemical mixtures occurring at 1188 hazardous waste sites, using the HazDat database.","volume":"34","author":"Fay","year":"1997","journal-title":"Food Chem Toxicol"},{"issue":"Suppl 2","key":"10.1124\/dmd.31.10.1203_bib8","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1289\/ehp.00108s2265","article-title":"Physiologically based pharmacokinetic models for trichloroethylene and its oxidative metabolites.","volume":"108","author":"Fisher","year":"2000","journal-title":"Environ Health Perspect"},{"key":"10.1124\/dmd.31.10.1203_bib9","series-title":"Determination of constants of water soluble chemicals for biologically based kinetic models.","author":"Frazier","year":"1998"},{"key":"10.1124\/dmd.31.10.1203_bib10","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0041-008X(85)90138-3","article-title":"Species differences in the response to trichloroethylene II. Biotransformation in rats and mice.","volume":"79","author":"Green","year":"1985","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1124\/dmd.31.10.1203_bib11","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1074\/jbc.271.2.861","article-title":"The kinetics, substrate and inhibitor specificity of the monocarboxylate (lactate) transporter of rat liver cells using the fluorescent intracellular pH indicator, 2\u2032,7\u2032-bis(carboxyethyl)-5(6)-carboxyfluorescein.","volume":"271","author":"Jackson","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.31.10.1203_bib12","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/0041-008X(92)90333-N","article-title":"Species differences in the metabolism of trichloroethylene to the carcinogenic metabolites trichloroacetate and dichloroacetate.","volume":"115","author":"Larson","year":"1992","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1124\/dmd.31.10.1203_bib13","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0090-9556(25)08748-3","article-title":"Species differences in protein binding of diflunisal.","volume":"17","author":"Lin","year":"1989","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.31.10.1203_bib14","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0022-3565(25)31137-7","article-title":"Serum protein binding and pharmacokinetics of valproate in man, dog, rat and mouse.","volume":"204","author":"Loscher","year":"1978","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.31.10.1203_bib15","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/BF00326650","article-title":"Trichloroethylene exposure and trichloroethylene metabolites in urine and blood.","volume":"29","author":"Muller","year":"1972","journal-title":"Arch Toxicol"},{"key":"10.1124\/dmd.31.10.1203_bib16","doi-asserted-by":"crossref","first-page":"C761","DOI":"10.1152\/ajpcell.1993.264.4.C761","article-title":"Transport of lactate and other monocarboxylates across mammalian cell membranes.","volume":"264","author":"Poole","year":"1993","journal-title":"Am J Physiol"},{"key":"10.1124\/dmd.31.10.1203_bib17","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1006\/taap.1996.0036","article-title":"In vivo and in vitro studies of perchloroethylene metabolism for physiologically based pharmacokinetic modeling in rats, mice and humans.","volume":"136","author":"Reitz","year":"1996","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1124\/dmd.31.10.1203_bib18","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1006\/taap.1999.8698","article-title":"Comparative toxicokinetics of chlorinated and brominated haloacetates in F344 rats.","volume":"158","author":"Schultz","year":"1999","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1124\/dmd.31.10.1203_bib19","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1016\/0006-2952(85)90322-3","article-title":"Specific and non-specific ligand binding to serum albumin.","volume":"34","author":"Taira","year":"1985","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.31.10.1203_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/taap.1993.1214","article-title":"Relative formation of dichloroacetate and trichloroacetate from trichloroethylene in male B6C3F1 mice.","volume":"123","author":"Templin","year":"1993","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1124\/dmd.31.10.1203_bib21","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1080\/15287399509531972","article-title":"Factors affecting species differences in the kinetics of metabolites of trichloroethylene.","volume":"44","author":"Templin","year":"1995","journal-title":"J Toxicol Environ Health"},{"key":"10.1124\/dmd.31.10.1203_bib22","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1006\/taap.1998.8548","article-title":"Biotransformation of perchloroethylene: dose-dependent excretion of trichloroacetic acid, dichloroacetic acid and N-acetyl-S-(trichlorovinyl)-l-cysteine in rats and humans after inhalation.","volume":"153","author":"Volkel","year":"1998","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1124\/dmd.31.10.1203_bib23","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1289\/ehp.99107103","article-title":"Exposure estimates to disinfection by-products of chlorinated drinking water.","volume":"107","author":"Weisel","year":"1999","journal-title":"Environ Health Perspect"},{"key":"10.1124\/dmd.31.10.1203_bib24","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1093\/toxsci\/54.2.302","article-title":"In vivo kinetics of trichloroacetate in male Fischer 344 rats.","volume":"54","author":"Yu","year":"2000","journal-title":"Toxicol Sci"},{"key":"10.1124\/dmd.31.10.1203_bib25","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1211\/0022357011775758","article-title":"Reversible binding of the novel anti-tumor agent 5,6-dimethylxanthenone-4-acetic acid to plasma proteins and its distribution into blood cells in various species.","volume":"53","author":"Zhou","year":"2001","journal-title":"J Pharm Pharmacol"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624027715?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624027715?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.31.10.1203","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T15:12:27Z","timestamp":1739891547000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624027715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,10]]},"references-count":25,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2003,10]]}},"alternative-id":["S0090955624027715"],"URL":"https:\/\/doi.org\/10.1124\/dmd.31.10.1203","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2003,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PLASMA BINDING OF TRICHLOROACETIC ACID IN MICE, RATS, AND HUMANS UNDER CANCER BIOASSAY AND ENVIRONMENTAL EXPOSURE CONDITIONS","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.31.10.1203","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2003 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}